ATE512152T1 - Pyrazolo-ä3,4-dü-pyramidinderivate als antiproliferative wirkstoffe - Google Patents

Pyrazolo-ä3,4-dü-pyramidinderivate als antiproliferative wirkstoffe

Info

Publication number
ATE512152T1
ATE512152T1 AT08786828T AT08786828T ATE512152T1 AT E512152 T1 ATE512152 T1 AT E512152T1 AT 08786828 T AT08786828 T AT 08786828T AT 08786828 T AT08786828 T AT 08786828T AT E512152 T1 ATE512152 T1 AT E512152T1
Authority
AT
Austria
Prior art keywords
pharmaceutically
compounds
pyrazolo
tumor
active ingredients
Prior art date
Application number
AT08786828T
Other languages
English (en)
Inventor
David Joseph Bartkovitz
Xin-Jie Chu
Kin-Chun Thomas Luk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE512152T1 publication Critical patent/ATE512152T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08786828T 2007-08-14 2008-08-04 Pyrazolo-ä3,4-dü-pyramidinderivate als antiproliferative wirkstoffe ATE512152T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95565307P 2007-08-14 2007-08-14
PCT/EP2008/060215 WO2009021869A1 (en) 2007-08-14 2008-08-04 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents

Publications (1)

Publication Number Publication Date
ATE512152T1 true ATE512152T1 (de) 2011-06-15

Family

ID=39760502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08786828T ATE512152T1 (de) 2007-08-14 2008-08-04 Pyrazolo-ä3,4-dü-pyramidinderivate als antiproliferative wirkstoffe

Country Status (12)

Country Link
US (1) US7968554B2 (de)
EP (1) EP2188290B1 (de)
JP (1) JP5296790B2 (de)
KR (1) KR20100038431A (de)
CN (1) CN101965349B (de)
AT (1) ATE512152T1 (de)
AU (1) AU2008288538A1 (de)
BR (1) BRPI0815334A2 (de)
CA (1) CA2694666C (de)
ES (1) ES2366268T3 (de)
MX (1) MX2010001636A (de)
WO (1) WO2009021869A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9408885B2 (en) 2011-12-01 2016-08-09 Vib Vzw Combinations of therapeutic agents for treating melanoma
EP3579872A1 (de) 2017-02-10 2019-12-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Verfahren und pharmazeutische zusammensetzungen zur behandlung von krebs in verbindung mit aktivierung der mapk-leitungsbahn
CA3086765A1 (en) 2017-12-28 2019-07-04 Tract Pharmaceuticals, Inc. Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
JP2022528705A (ja) * 2019-04-10 2022-06-15 セレスティア バイオテック アーゲー オンコウイルス誘発性がんの治療のための化合物及びその使用方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732970B1 (fr) 1995-04-14 1997-05-16 Hoechst Schering Agrevo Sa Nouveaux derives de l'acide beta-methoxy acrylique, leur procede de preparation et leur application comme pesticides
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
DK1140938T3 (da) 1999-01-11 2003-12-22 Univ Princeton Højaffinitetsinhibitorer for målvalidering og anvendelser heraf
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
MXPA03004714A (es) 2000-11-28 2003-08-19 Pfizer Prod Inc Sales de una isotiazol-4-carboxamida y su uso como agentes de antihiperproliferacion.
MXPA04009541A (es) 2002-03-29 2005-01-25 Chiron Corp Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
EP1556053A4 (de) * 2002-10-31 2006-04-19 Amgen Inc Entzündungshemmende mittel
US7592352B2 (en) 2003-05-06 2009-09-22 Smithkline Beecham Corporation Substituted thieno and furo-pyridines
US20050026944A1 (en) * 2003-07-24 2005-02-03 Patrick Betschmann Thienopyridine and furopyridine kinase inhibitors
US20050020619A1 (en) * 2003-07-24 2005-01-27 Patrick Betschmann Thienopyridine kinase inhibitors
US7202363B2 (en) * 2003-07-24 2007-04-10 Abbott Laboratories Thienopyridine and furopyridine kinase inhibitors
WO2005056562A1 (en) 2003-12-05 2005-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors
WO2005074603A2 (en) * 2004-02-03 2005-08-18 Abbott Laboratories Aminobenzoxazoles as therapeutic agents
US20050256154A1 (en) * 2004-05-04 2005-11-17 Kin-Chun Luk 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
US7405220B2 (en) 2004-06-09 2008-07-29 Hoffmann-La Roche Inc. Pyrazolopyrimidines
US9512125B2 (en) 2004-11-19 2016-12-06 The Regents Of The University Of California Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
US7566716B2 (en) 2005-05-20 2009-07-28 Array Biopharma Inc. Imidazopyrazines as Raf inhibitor compounds
MY153898A (en) * 2005-06-22 2015-04-15 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
EP1926737B1 (de) * 2005-09-15 2017-03-15 F. Hoffmann-La Roche AG 4-amino-thieno [3,2-c]pyridin-7-carbonsäure-derivate
WO2007067781A2 (en) * 2005-12-08 2007-06-14 Abbott Laboratories 9-membered heterobicyclic compounds as inhibitors of protein kinases
US20080299113A1 (en) 2005-12-19 2008-12-04 Arnold Lee D Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents

Also Published As

Publication number Publication date
WO2009021869A1 (en) 2009-02-19
US20090048274A1 (en) 2009-02-19
AU2008288538A1 (en) 2009-02-19
US7968554B2 (en) 2011-06-28
CA2694666A1 (en) 2009-02-19
KR20100038431A (ko) 2010-04-14
ES2366268T3 (es) 2011-10-18
CN101965349A (zh) 2011-02-02
EP2188290A1 (de) 2010-05-26
JP5296790B2 (ja) 2013-09-25
MX2010001636A (es) 2010-03-15
EP2188290B1 (de) 2011-06-08
CN101965349B (zh) 2016-05-04
CA2694666C (en) 2015-07-14
BRPI0815334A2 (pt) 2019-09-24
JP2010535835A (ja) 2010-11-25

Similar Documents

Publication Publication Date Title
BRPI0510560A (pt) pirido[2,3-d] pirimidin-7-onas pirrolil substituìdas e seus derivados como agentes terapêuticos
BRPI0409366A (pt) compostos de pirimido
UY27937A1 (es) Compuestos pirimido que tienen actividad antiproliferativa
MX2009010034A (es) Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.
EA201000552A1 (ru) Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
IL260127B (en) mek inhibitors and methods of using them
EA202090659A1 (ru) СОСТАВЫ, СОДЕРЖАЩИЕ 6-(2-ГИДРОКСИ-2-МЕТИЛПРОПОКСИ)-4-(6-(6-((6-МЕТОКСИПИРИДИН-3-ИЛ)МЕТИЛ)-3,6-ДИАЗАБИЦИКЛО[3.1.1]ГЕПТАН-3-ИЛ)ПИРИДИН-3-ИЛ)ПИРАЗОЛО[1,5-a]ПИРИДИН-3-КАРБОНИТРИЛ
WO2006018182A8 (en) Combinations for the treatment of diseases involving cell proliferation
WO2009007748A3 (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
PA8601901A1 (es) Pirazoles como inhibidores de factor de necrosis tumoral
WO2009007749A3 (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
MX2010006739A (es) Compuestos pirido[2,3-b]pirazina-8-sustituidos y su uso.
CL2012000592A1 (es) Compuestos derivados de fenoxi o fenil-tieno[3,2-b]piridina, inhibidores de tirosina quinasas; composicion farmaceutica; y su uso en el tratamiento de cancer colorrectal, de pulmon, hematologico, de higado, mama, en retinopatia diabetica, degeneracion macular, glaucoma, psoriasis, diabetes, enfermedades neurodegenerativas, entre otras.
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
EA201000090A1 (ru) Тризамещенные производные пиримидина для лечения пролиферативных заболеваний
DE602006014579D1 (de) Heteroalkylgebundene pyrimidinderivate
BRPI0511975A (pt) pirazolopirimidinas
EA201070013A1 (ru) СОЛИ ИНГИБИТОРА ЯНУС-КИНАЗЫ (R)-3-(4-(7H-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1H-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
MX2012002327A (es) Inhibidores de cinasa, formas de profarmaco de los mismos y su uso en terapia.
UA95230C2 (ru) ЗАМЕЩЕННЫЕ ТЕТРАГИДРОПИРИМИДО[4,5-d]ПИРИМИДИНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИХ, И ИХ ПРИМЕНЕНИЕ
BRPI0815334A2 (pt) derivados de pirazolo[3,4-d]-piramidina como agentes antiproliferativos
EA200501233A1 (ru) 4-аминопиримидин-5-он
EA200800223A1 (ru) ПРОИЗВОДНЫЕ ПИРИДО[2,3-d]ПИРИМИДИНА, ИХ ПОЛУЧЕНИЕ, ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
BRPI0520482A2 (pt) amidas do ácido 4-amino-tieno [3,2-c] piridina-7-carboxìlico

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties